Physician

Andrew Mcneil, D.O.

According to 2025 Medicare claims, Andrew Mcneil, D.O. (NPI: 1356637797) practices pain management in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is SOUND PAIN ALLIANCE (NPI: 1649776394; TIN: 823663428) and primary practice location at 98383-8583. Mcneil is affiliated with the Jefferson Accountable Care, LLC (ACO ID: A5275) and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Mcneil's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,345 traditional Medicare patients, billed 11,114 HCPCS/CPT codes, and received $620,225 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 270 prescription claims across 92 beneficiaries totaling $6,106 in drug costs, led by Lidocaine (Lidocaine). 2023 DME data shows 14 claims. Open Payments data shows 20 records totaling $755. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $42,627 to $620,225. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $13,318 and ending at $6,106. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	137	605	$42,627
2017	470	3,521	$254,223
2018	431	1,808	$140,870
2019	417	1,433	$121,953
2020	530	4,552	$259,377
2021	462	7,086	$318,594
2022	1,236	9,421	$550,760
2023	1,359	10,664	$628,339
2024	1,345	11,114	$620,225

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	58	213	$13,318
2017	127	608	$48,558
2018	74	271	$21,341
2019	87	195	$7,217
2020	175	614	$36,613
2021	128	535	$50,824
2022	122	366	$16,244
2023	104	274	$8,660
2024	92	270	$6,106

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	15	15	$12,542
2021	54	54	$32,603
2022	23	23	$13,437
2023	14	14	$9,703
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	148	193	$214
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,166	3,445	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	136	177	$64
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	309	581	$0
J1100	Injection, dexamethasone sodium phosphate, 1 mg	285	4,840	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lidocaine	Lidocaine	11	330	$1,445
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	702	$998
Morphine Sulfate Er	Morphine Sulfate	20	560	$667
Gabapentin	Gabapentin	32	1,080	$550
Hydromorphone Hcl	Hydromorphone Hcl	18	421	$358

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$755	Nevro Corp.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Mcneil, D.O.?

Tedicare shows public-source Medicare data for Andrew Mcneil, D.O. (NPI 1356637797), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Mcneil, D.O. have ACO affiliation data?

Andrew Mcneil, D.O. is shown with ACO affiliation data for Jefferson Accountable Care, LLC (MSSP, ACO ID A5275) and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Andrew Mcneil, D.O.?

Andrew Mcneil, D.O. is linked to SOUND PAIN ALLIANCE (billing NPI 1649776394) in the available physician profile data.

Does Andrew Mcneil, D.O. have Open Payments data?

Andrew Mcneil, D.O. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.